Expression levels of sulfomucin in human colonic adenocarcinomas are lower than those in normal colonic mucosa; this should be in part caused by down-regulation of expression of sulfotransferases, but it remains unclear which Gal 3-O-sulfotransferase (Gal3ST) is responsible for the biosynthesis of sulfomucin. In this study, we first examined the substrate specificities of four Gal3STs cloned so far, and found that Galβ β β β1 → → → →3GlcNAcβ β β β1 → → → → 3Galβ β β β1 → → → →4Glc (LNT) can be utilized only byGal3ST-2 as an acceptor substrate. The substrate specificity of Gal3ST-2 is closely similar to those of Gal3ST activities present in human normal mucosa and adenocarcinomas, suggesting that Gal3ST-2 is the dominant Gal3ST in colon and colonic cancer. Secondly, using LNT as a substrate, we comparatively analyzed levels of Gal3ST-2 activities in non-mucinous adenocarcinoma, mucinous adenocarcinomas, and the adjacent normal mucosa. We found that levels of Gal3ST-2 activities in non-mucinous adenocarcinoma are significantly lower than those in the adjacent normal mucosa, while those in mucinous adenocarcinomas are not significantly different from those in the adjacent normal mucosa. Moreover, we showed by a competitive RT-PCR method that expression levels of transcript for Gal3ST-2 in non-mucinous adenocarcinoma are lower than those in normal mucosa. These results suggest that Gal3ST-2 is one of the enzymes responsible for biosynthesis of sulfomucin, and that expression levels of Gal3ST-2 are down-regulated in non-mucinous adenocarcinoma.Key words: Colon cancer -Sulfomucin -Sulfotransferase -Gal3ST -Type 1Sulfomucin is a glycoprotein containing large amounts of O-linked, sulfated glycans. It is well-known that expression levels of sulfomucin in colonic cancer are markedly lower than those in the adjacent normal mucosa.
1, 2)Yamori et al.3) explored a monoclonal antibody, 91.9H, recognizing sulfated glycans in sulfomucin, and Irimura et al. 4) and Matsushita et al. 5) showed that expression levels of the epitope in colonic adenocarcinomas are indeed lower than those in normal mucosa. Thereafter, Loveless et al. 6) showed that the minimum epitope moiety is the SO 3 − →3Galβ1→3(Fucα1→4)GlcNAcβ1→3Galβ1→ structure. These results suggest that the decrease of the epitope in colon cancer is at least partly associated with that of sulfomucin. We previously showed that levels of the enzymatic activities of β1,3-galactosyltransferase, which can synthesize the backbone structure of the 91.9H antigen, are lower in colonic adenocarcinomas than in the adjacent normal mucosa. 7) Thereafter, Salvini et al. 8) showed that expression of β3GalT-V gene is down-regulated in colonic adenocarcinomas, suggesting that β3GalT-V gene is involved in biosynthesis of the 91.9H antigen and its low expression in colonic adenocarcinomas. However, it remains unclear whether or not 3-O-sulfation at the Gal residue is also down-regulated in the course of colonic carcinogenesis. Gal3ST transfers sulfate from PAPS to the C-3 position of Gal residu...